MDT
Medtronic plc · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +4.2% ·
aandelenstroom +1.6% ·
netto nieuwe posities +4.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.44M | $115.59M | n/a | n/a |
| Q2 2026 | 175 | +1 | 871.51M | $69.43B | +6 | −4 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | n/a |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | n/a | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | n/a |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | n/a | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | n/a |
| Q2 2024 | 20 | n/a | 97.49M | $7.67B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 126.91M | n/a | $11.06B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 122.45M | n/a | $10.67B | 0.2% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 59.83M | -0.3% | $5.26B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 28.23M | +1.1% | $2.45B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 16.44M | +12.3% | $1.43B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 9.80M | +13.1% | $853.99M | 0.8% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Dodge & Cox ✦ | 7.74M | +0.4% | $674.73M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 7.53M | +89.8% | $656.44M | 0.1% | ▲ Add | 5 | SEC ↗ ×8 |
| 9 | T. Rowe Price ✦ | 6.05M | -39.9% | $527.05M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Capital World Investors ✦ | 5.52M | +10.6% | $480.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 4.02M | +333.4% | $350.65M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 2.40M | +10.3% | $209.23M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 1.98M | -41.3% | $172.47M | 0.1% | ▼ Trim | 5 | SEC ↗ ×6 |
| 14 | Adage Capital Partners ✦ | 1.80M | +4.5% | $157.32M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 1.62M | n/a | $141.33M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Arrowstreet Capital ✦ | 1.49M | +332.0% | $130.30M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 863.89K | -10.4% | $75.31M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 18 | Baillie Gifford ✦ | 492.85K | -2.4% | $42.96M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 19 | PRIMECAP Management ✦ | 448.99K | -32.7% | $39.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 432.54K | Nieuw | $37.70M | 0.1% | New | 1 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 320.67K | +1610.4% | $27.95M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 274.07K | -70.0% | $23.89M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 257.88K | +76.3% | $22.48M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 202.17K | +19.2% | $17.62M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 160.37K | +3424.7% | $13.98M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $37.70M | 0.1% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2,204 houders, 1.04B aandelen, $87.65B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 10.42K aand · $1.00M
Officer, Director · 50.00K aand · $4.75M
Officer · 1.48K aand · $138,883
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie